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The herpes simplex virus large subunit of ribonu-
cleotide reductase differs from its counterparts in
eukaryotic and prokaryotic cells and in other viruses
in that it contains a unique domain that codes for a
distinct serine-threonine protein kinase that activates
the Ras/MEK/MAPK mitogenic pathway and is
required for virus growth. Previous studies suggested
that ribonucleotide reductase protein kinase was co-
opted from a cellular gene. Cellular genes similar to
ribonucleotide reductase protein kinase were not
cloned, however, and their function is unknown.
Here we report that a novel gene (H11) that codes
for a protein similar to herpes simplex virus 2 ribo-
nucleotide reductase protein kinase, is expressed in
skin tissues, cultured keratinocytes, and the keratino-
cyte cell line A431. The protein is phosphorylated
and it associates with the plasma membrane. H11 is
expressed in keratinocytes with long-term in vitro
growth potential and is coexpressed with high levels
of adhesion molecules involved in signal transduc-
tion, such as b1 integrin. Antisense oligonucleotides
that inhibit H11 expression inhibit DNA synthesis
and keratinocyte proliferation, suggesting that H11
expression is required for cell growth. Key words: cell
adhesion proteins/epidermis/HSV-2/RR1 PK/stem cells. J
Invest Dermatol 116:286±295, 2001
W
ithin the epidermis, proliferation takes place in
the basal layer of keratinocytes. Three sub-
populations of basal keratinocytes were de®ned
by cell kinetics analyses (Milstone and LaVigne,
1985; Barrandon and Green, 1987; Jones and
Watt, 1993). They include: (i) stem cells that have a high capacity
for self-renewal throughout the adult life; (ii) transit-amplifying
cells that divide a number of times but have a high propensity to
produce daughters that are committed to terminal differentiation;
and (iii) committed cells that detach from the basement membrane
and move upwards from the basal layer by a mechanism that may
involve inactivation of the b1 integrin receptors on the cell surface
(Hotchin et al, 1993). In vitro, keratinocytes were found to be
heterogenous with respect to their cycling times, rates of cell cycle
withdrawal, and clonal properties. Whereas growth potential is
lower for adult than neonatal keratinocytes (Rheinwald and Green,
1975; Milstone and LaVigne, 1985; Albers et al, 1986; Barrandon
and Green, 1987; Dover and Potten, 1988), it is generally accepted
that a subpopulation of basal keratinocytes exhibits greater overall
proliferative capacity, which is re¯ected in relatively long-term in
vitro growth potential (Barrandon and Green, 1987; Morris and
Potten, 1994, 1999; Kolodka et al, 1998). The genes/functions that
are responsible for this increased growth potential are unknown.
They may include members of mitogenic signaling pathways such
as the mitogen-activated protein kinase (MAPK) (Zhu et al, 1999)
or the b- (Zhu and Watt, 1999) or g- (MoleÁs and Watt, 1997)
catenins, and/or proliferation-associated proteins such as the
antigen recognized by antibody 10G7 (Kaur and Li, 2000).
The studies described in this report are based on previous,
unpublished ®ndings that a protein in A431 cells (keratinocytes) is
recognized by antibody to a herpes simplex virus type 2 (HSV-2)
protein designated RR1 PK. RR1 PK is a serine-threonine speci®c
protein kinase (PK) coded by the chimeric HSV gene for the large
subunit of ribonucleotide reductase (RR1). Unlike other known
PKs that have at least 12 conserved PK catalytic motifs (Taylor et al,
1992; Hanks and Hunter, 1995), RR1 PK functions with only
eight such motifs (Chung et al, 1989; 1990; Luo et al, 1991; Luo
and Aurelian, 1992; Smith et al, 1992; 1998; Cooper et al, 1995;
Nelson et al, 1996; Peng et al, 1996; Aurelian, 1998) and is a
member of a distinct phylogenetic subfamily of serine-threonine
PKs (Hunter et al, 1995a). The HSV-2 RR1 PK activates the Ras/
MEK/MAPK mitogenic pathway (Smith et al, 1994, 2000a;
Hunter et al, 1995b), which is important for promoting cell cycle
progression into S phase (Karin et al, 1997) and is required for virus
growth (Smith et al, 1998). Because the PK domain is uniquely
present in the HSV RR1 proteins and homologous sequences were
identi®ed in human cells, it has been suggested that the PK domain
originated from a co-opted cellular gene (Smith et al, 1991).
Cellular genes homologous to RR1 PK were not cloned, however,
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and their function is unknown. Here we describe a novel gene
designated H11 that codes a protein similar to RR1 PK. H11 is
expressed in basal keratinocytes that have long-term in vitro growth
potential and its expression appears to be required for keratinocyte
growth in culture.
MATERIALS AND METHODS
Cells and tissues HeLa (human cervical cancer), A431 (human
keratinocytes), and 293 (adenovirus E1a-immortalized human embryonic
kidney) cells were obtained from American Type Culture Collection. A431
cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) with
10% fetal bovine serum (FBS) (Hyclone Labs, Logan, UT). 293 cells were
grown in Eagle's modi®ed minimal essential medium (EMEM)
supplemented with 1 mM nonessential amino acids, 1% sodium pyruvate,
and 10% FBS. HeLa cells were grown in EMEM with 10% FBS. Human
keratinocyte cultures were prepared using the methods described by
Rheinwald and Green (1975). Keratinocytes were obtained from samples
of meshed, split thickness biopsies taken during the grafting of adult (ages
30±65 y) burn patients at the Baltimore Regional Burn Center. Cells were
harvested by trypsinization, washed in serum-free medium, counted, and
stored frozen until use. Cultures were set in 25 cm2 tissue culture ¯asks by
coincubating 5 3 105±8 3 105 keratinocytes with an equal number of
irradiated 3T3 feeder cells in 5 ml of complete medium consisting of
DMEM and Ham's F12 nutrient mixture (3:1) and supplemented with 5 mg
per ml insulin, 0.4 mg per ml hydrocortisone, 1.8 3 10±4 M adenine, 2 3 109
M triiodothyronine (all from Sigma, St. Louis, MO), 10±10 M cholergen
(ICN Labs, Aurora, OH) 10 ng per ml epidermal growth factor (Gibco
BRL, Gaithersburg, MD), and 10% FBS (Hyclone Labs) (Green et al,
1979). These cells exhibited growth characteristics similar to those
previously described for adult keratinocytes (Rheinwald and Green,
1975). Biopsies of normal tissues (spleen, thymus, testes, ovary, pancreas,
kidney, liver, lung, and brain) were obtained from the pathology service
(University of Maryland). Skin biopsies were obtained from the arms of
three normal subjects who also donated peripheral blood leukocytes.
Antibodies Polyclonal antibodies to peptides that, respectively, represent
H11 amino acids 10±29 (CHYPSRLRRDPFRDSPLSSR; N-terminal) or
181±194 (SFNNELPQDSQEVT; C-terminal) were conjugated to keyhole
limpet hemocyanin, puri®ed, and injected into rabbits, as previously
described (Aurelian et al, 1989). Preimmune serum was used as control for
the H11 antibodies. Monoclonal antibodies (MoAbs) to keratin K10 (IgG1)
(Dako, Carpinteria, CA), b-catenin (MoAb E-5; IgG1), and b1 integrin
(MoAb 4B7R; IgG1) (Santa Cruz Biotechnology, Santa Cruz, CA) were
obtained commercially and used according to the manufacturer's
instructions. Isotype-matched mouse unconjugated negative control
reagent (IgG1; Cat # X0931) was obtained from Dako.
Library screening and plasmid construction An established
preampli®ed HeLa cDNA (UniZap XR) library (Stratagene, LaJolla,
CA), constructed in a lambda based vector, was screened with antibodies to
RR1 PK peptides (Aurelian et al, 1989; Chung et al, 1990). The
preparation of host bacterial cultures (E. coli XL1 blue MRF¢), lambda
library infection/plating, and cDNA expression (on IPTG impregnated
nitrocellulose ®lters), as well as antibody-based screening (immuno-
blotting), were performed as per the manufacturer's instructions. A total
of 1 3 106 plaques were screened and positive plaques were subjected to
three successive rounds of puri®cation through plaque isolation and re-
screening. Eight pure plaque isolates were obtained that contained cDNA
sequences. Single-stranded cDNA contained within an ssDNA Bluescript II
phagemid (Stratagene) was rescued, isolated, and puri®ed from lambda
clones using freshly titered helper phage VCM13 according to the
manufacturer's instructions. ssDNA was sequenced (UMAB Biopolymer
Laboratory) using primers speci®c for either Bluescript II or cDNA
sequences. cDNA was rescued as a double-stranded Bluescript II phagemid
using the ExAssist/SOLR System (Stratagene) according to the
manufacturer's instructions and designated H11.
RNA isolation and northern blot hybridization Total cellular RNA
was isolated with RNAzol (Tel-Test, Friendswood, TX) as per the
manufacturer's instructions and used in northern blot hybridization as
described previously (Feng et al, 1996; Smith et al, 1998). Prehybridization
was in a solution containing 50% formamide, 5 3 sodium citrate/chloride
buffer (SSC) (1 3 is 0.15 M NaCl, 0.01 M NaH2PO4.H2O, 1 mM
ethylenediamine tetraacetic acid, pH 7.4), 10 3 Denhardt's (13 is 2%
polyvinylpyrolidone, 2% Ficoll, 2% bovine serum albumin), 1% sodium
dodecyl sulfate (SDS), and 100 mg per ml heat denatured salmon sperm
DNA for 5 h at 42°C. Hybridization was for 20 h at 42°C with [32P]-
labeled probes in the prehybridization solution. The H11 probe was the 1.8
kb EcoRI/XhoI cDNA fragment. A g-actin cDNA probe (Leader et al,
1985) served as control. Probes were [a-32P]dCTP labeled by the random
priming method using an oligonucleotide kit (Pharmacia, Piscataway, NJ)
as per the manufacturer's instructions. Blots were washed four times in 2 3
SSC with 0.05% SDS (40 min; 20°C) followed by two washes with 0.1 3
SSC and 0.1% SDS (40 min; 50°C) and visualized by autoradiography.
Reverse transcriptase polymerase chain reaction (RT-PCR) Total
cellular RNA was used in RT-PCR as previously described (Kokuba et al,
1999). RNA was incubated with 250 units of DNAse I (Boehringer
Mannheim, Indianapolis, IN) for 1 h at 37°C. To generate cDNA, 2 mg
DNAse I-treated RNA was incubated with 200 units MMTV reverse
transcriptase (Gibco BRL), 400 mM deoxynucleoside triphosphates
(dNTP), reverse transcriptase buffer (10 mM Tris-HCl pH 8.5, 15 mM
keratinocytel, 0.6 mM MgCl2), 10 mM dithiothreitol, and 10 pmol
(0.5 mM) of antisense H11 or actin primers for 1 h at 42°C. Each PCR
was done with one-tenth of the generated cDNA. PCRs were with 10
pmol (0.5 mM) of the H11 sense and antisense primers (5¢-
CCATGGCTGACGGTCAGATGCCCTTCTCCT-3¢ and 5¢-
TCCATGCCAAAGCCATCATCCAGCAG-3¢) or b-actin sense and
antisense primers (5¢-GTGGGGCGCCCCAGGCACCA-3¢ and 5¢-
CTCCTTAATGTCACGCACGATTTC-3¢) and the AdvanTaq Plus kit
(Clontech, Palo Alto, CA). The PCR program included 1 min at 94°C for
1 cycle, 94°C for 30 s, and 68°C for 2 min. There were 26 cycles with a
®nal extension of 5 min at 68°C on a Perkin Elmer thermocycler (Model
9700). Products were analyzed by electrophoresis on 8% acrylamide gels
and subsequent staining with 0.5 mg per ml ethidium bromide. The relative
abundance of H11 RNA was estimated by ®rst normalizing to the value of
actin RNA in each sample by densitometric scanning using a BioRad GS-
700 Imaging Densitometer.
Immunoprecipitation/immunoblotting Immunoprecipitation/im-
munoblotting assays were done as previously described (Smith et al, 1994,
1998; Nelson et al, 1996). For immunoprecipitation, cells were resuspended
in cold RIPA buffer [0.01 M Tris-HCl (pH 8.0), 0.1% SDS, 1% Nonidet P-
40, 1% deoxycholate, 0.15 M NaCl] with 1 mM phenylmethylsulfonyl
¯uoride and 100 Kallikrein units per ml aprotinin (Sigma) for 15 min on
ice, and cleared of cell debris by centrifugation for 30 min at 20,000 3 g.
They were incubated (1 h, 4°C) with 15 ml of antibody and (30 min, 4°C)
with 100 ml protein A-Sepharose CL4B beads (10 mg; Sigma) in a buffer
consisting of 0.1 M Tris-HCl (pH 8.0), 0.15 M NaCl, and 0.5% Nonidet P-
40. Beads were washed extensively with ice-cold RIPA buffer, and bound
proteins were eluted by boiling (5 min) in 100 ml denaturing solution
[150 mM Tris-HCl (pH 7.0), 5.7% SDS, 14% 2-mercaptoethanol, 17%
sucrose, and 0.04% bromothymol blue]. Proteins were resolved by SDS
polyacrylamide gel electrophoresis on 7% or 8.5% polyacrylamide gels and
visualized by autoradiography. Gels of cell extracts or immunoprecipitates
were electrotransferred onto nitrocellulose membranes and
immunoblotting was performed by incubation with the respective
antibodies followed by protein A-peroxidase (Sigma) for 1 h at room
temperature each. Detection was with enhanced chemiluminescence
reagents (Amersham, Arlington Heights, IL) as per the manufacturer's
instructions.
Immuno¯uorescent (FA) staining, confocal microscopy, and ¯ow
cytometry Un®xed and acetone-®xed cells were stained with
¯uorescein isothiocyanate (FITC)-labeled H11 antibody or preimmune
serum and phycoerythrin-labeled antibodies to other proteins. Stained cells
were visualized with an epi¯uorescent confocal microscope ®tted with an
argon ion laser (Zeis LSM410). Cells staining with preimmune serum
(control for H11 antibody) or isotype-matched IgG (control for
monoclonal antibodies) were excluded by gating the brightness and
contrast settings on the confocal microscope. One thousand gated cells
(identi®ed by nuclear staining with propidium iodide or Hoechst) were
counted and the proportion that was FA positive was determined. To
estimate the proportion of cells with high intensity b1 integrin or b-catenin
staining, brightness and contrast settings were ®rst set to visualize all the
positive cells (bright + dim) and then reset to visualize only the bright cells.
Results are expressed as percentage bright cells = [bright cells/(bright + dim
cells)] 3 100. The same settings were used to calculate the percentage of
bright cells on all slides. A FACScan ¯ow cytometer (Becton Dickinson
Immunocytometry Systems, San Jose, CA) equipped with a 15 mW argon
laser with 488 nm excitation was used in ¯ow cytometry experiments, as
previously described (Aurelian et al, 1979; Luo and Aurelian, 1992; Smith
et al, 1994). Fluorescence from FITC-labeled cells was collected using a
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530/30 nm band pass ®lter whereas phycoerythrin ¯uorescence was
measured with a 580/25 nm band pass ®lter. Percentages of positively
stained cells and the mean ¯uorescence calculations were determined from
the histogram and dot plot displays using CellQuest software (Becton
Dickinson Immunocytometry Systems).
Immunohistochemistry The Dako LSAB2 kit was used for
immunoperoxidase staining. Sections of formalin-®xed tissues were
exposed (30 min, room temperature) to H11 antibody followed (10 min)
by the biotinylated secondary antibody (antirabbit Igs). They were stained
with the peroxidase kit as per the manufacturer's instructions and
counterstained with Mayer's hematoxylin (Kokuba et al, 1999).
Effect of H11 antisense oligonucleotide (ODN) on DNA synthesis
and cell growth To examine the effect of the antisense ODN on DNA
synthesis, A431 cells (5 3 103) were incubated in triplicate in 96-well plates
in 0.1 ml of culture medium supplemented with 10% heat-inactivated FBS
for 30 min at 65°C to destroy nuclease activity and were cultured (24 h) in
the presence or absence of antisense, sense, or randomly scrambled ODNs
(Smith et al, 1986; Kulka et al, 1989, 1993; Care et al, 1996; Feng et al,
1996). The ODN sequences were ®rst tested against sequences in the
GenBank database. Antisense ODN (aODN) was complementary to
sequences that encompass the H11 translation initiation site (3¢-
GGTACCGACTGCCAGT-5¢). Scrambled ODN (3¢-TACTAACGAC-
CTCGTG-5¢; scODN) and sense ODN (5¢-CCACCATGGCTGACGG-
3¢; sODN) were studied in parallel. Cells were treated (24 h) with the
ODNs and labeled with [3H]-thymidine ([3H]-TdR, 2.5 mC; New England
Nuclear) during the last 4 h of treatment. The radioactivity on the ®lters
was determined with a Beckman LS6800 liquid scintillation counter
(Wachsman et al, 1989). Antisense inhibition was calculated relative to that
of sc-ODN, whose inhibition did not exceed 15% of the proliferation rate
shown by untreated cells. The concentration (30 mM) that showed maximal
inhibition of DNA synthesis was used to examine the effect of aODN on
keratinocyte proliferation. Keratinocyte cultures were initiated in medium
with or without aODN and re-fed with the same medium three times
weekly. At 12 d in culture, the ¯asks were washed with phosphate-buffered
saline and stained with Rhodamine B that preferentially stains keratinocyte
colonies (Barrandon and Green, 1987). The stained colonies were washed
with water to remove the excess dye, drained, and dried. The dye taken up
by the cells was eluted by extraction with methanol and its optical density
was read at 570 nM. Uptake was determined using a standard curve
established from repeated measurements taken at six to eight intervals
during the growth phase and plotted against the percentage con¯uence.
The results are expressed as con¯uence index relative to untreated cells, in
which 1 = 100% con¯uence.
RESULTS
Isolation of H11 cDNA and computer-assisted predictions
of protein properties Because sequences homologous to RR1
PK were previously found in HeLa cells (Smith et al, 1991) and a 25
kDa protein that cross-reacts with antibodies to HSV-2 RR1 PK
was precipitated from these (as well as A431) cells (unpublished),
we used the RR1 PK antibodies to screen a commercially available
HeLa cDNA library. A total of 1 3 106 plaques were screened by
immunoblotting and puri®ed as described in Materials and Methods.
Eight pure plaque isolates were obtained that contained cDNA
sequences. Single-stranded cDNA contained within one phagemid
was rescued, isolated, and puri®ed. This cDNA, designated H11,
was subcloned and sequenced. It consists of 1835 bp (GenBank
accession No. AF133207), a size similar to that of RR1 PK, and
contains one open reading frame (ORF) of 588 nucleotides. This
would encode a protein of 196 amino acids with a calculated
molecular weight of 21.5 kDa (Fig 1). Signi®cant homology was
not observed to sequences in the nonredundant SwissProt database
when using the BLASTX 2.0.13 program. Using the FASTA
program to search the GenBank database, however, there was a
40% identity to the small heat shock protein hsp27. Computer-
assisted analysis of the predicted amino acid sequence in the H11
ORF revealed the presence of seven potential conserved PK
catalytic motifs when allowing for conservative substitutions. This
includes a partially conserved catalytic motif I and a conserved
catalytic motif II (invariant Lys; residues 112±114), which is part of
the stable scaffolding of kinase active sites and is required for kinase
activity (Montell and Rubin, 1988; Taylor et al, 1992; Hanks and
Hunter, 1995). A potential catalytic motif VI that retains the
invariant Asn residue and is a strong indicator of serine-threonine
speci®city (Montell and Rubin, 1988; Taylor et al, 1992; Hanks and
Hunter, 1995) was also seen at residues 133±138. Using the ALIGN
program (Genestream, IGH Montpelier, France), there was a 30%
level of identity to RR1 PK over the H11 PK catalytic domain
(115 amino acids). Additional motifs shared with RR1 PK are two
potential myristylation sites (Gly-X-X-X-Ser/Thr; residues 62 and
132) and an SH3-binding site (PPPFPGEP; amino acids 88±95)
involved in protein±protein interactions (Pawson, 1995).
H11 RNA is expressed in keratinocyte cultures and skin
tissues To examine whether H11 is expressed in keratinocytes
and to determine the size of the H11 transcript, we used northern
blot hybridization with H11 cDNA. Actin cDNA served as a
control for loading. A 1.8 kb band, consistent with the H11
transcript, was seen in HeLa (Fig 2A, lane 1) and A431 (Fig 2A,
lane 2) cells, but not 293 (Fig 2A, lane 3) cells. The failure to detect
H11 RNA in 293 cells is not an artefact due to improper gel
loading, as similar levels of actin RNA were seen in all assays
(Fig 2A, lanes 1±3). To examine whether H11 is expressed in the
skin and to begin to de®ne the spectrum of H11 expression in
human tissues, we used RT-PCR, which is more sensitive than
northern hybridization and can be used with the limited amounts of
RNA from these tissues. A 110 bp ampli®cation product consistent
with H11 was seen in HeLa cells that were used as positive control
(Fig 2B, lane 13), but not in 293 cells that were used as negative
control (Fig 2B, lane 14). The ampli®cant was also seen in all skin
tissues, as shown for one of these in Fig 2(B), lane 12. It was not
seen in adult brain, lung, kidney, liver, pancreas, thymus, testes,
ovary, spleen, and peripheral blood leukocytes (Fig 2B, lanes 2±11).
This is not an artefact due to insuf®cient levels of RNA, technical
dif®culties, or improper loading, as virtually identical levels of the
actin ampli®cant were seen in all samples (Fig 2B, lanes 2±14). We
interpret the data to indicate that H11 is expressed in the skin,
probably in keratinocytes, but its expression at detectable levels is
not widely distributed.
H11 protein is expressed in keratinocytes and is
phosphorylated To examine whether a protein of the
Figure 1. H11 nucleotide sequence and predicted amino acid
sequence. Numbers on the left represent nucleotides.
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predicted H11 size is expressed in keratinocytes, we used
immunoprecipitation/immunoblotting studies with antibodies to
H11 peptides. In addition to keratinocytes (obtained on day 14 in
culture), we also studied A431, HeLa, and 293 cells, which are,
respectively, positive (HeLa and A431) or negative (293) for H11
RNA. To control for the possibility that H11 shares an epitope
with an unrelated protein, cell extracts were immunoprecipitated
with H11 N-terminal antibody (recognizes amino acids 10±29) and
immunoblotted with H11 C-terminal antibody (recognizes amino
acids 181±193). Preimmune serum served as control. A 25 kDa
protein consistent with H11 was recognized by the H11 antibodies
in keratinocytes (Fig 3A, lane 1), A431 cells (Fig 3A, lane 3), and
HeLa cells (data not shown). It was not seen in 293 cells (Fig 3A,
lane 5) and preimmune serum was negative (Fig 3A, lanes 2, 4, 6).
Inasmuch as this protein is larger than predicted, we considered the
possibility that it is post-translationally modi®ed, possibly by
phosphorylation, like RR1 PK (Chung et al, 1989; Cooper et al,
1995; Nelson et al, 1996; Peng et al, 1996; Smith et al, 1998). To
test this interpretation, A431 cells were labeled with [32P]-
orthophosphate for 4 h and the extracts were precipitated with
the H11 N-terminal or C-terminal antibodies or with preimmune
serum, used as control. A phosphorylated 25 kDa protein was
precipitated by the N-terminal (Fig 3B, lane 1) and C-terminal
(Fig 3B, lane 2) H11 antibodies, but not by preimmune serum
(Fig 3B, lane 3), and similar results were obtained in keratinocytes
(data not shown). We interpret the data to indicate that the H11
protein is expressed in keratinocytes and it is phosphorylated.
H11 protein is expressed in keratinocytes with long-term in
vitro growth potential To examine the effect of in vitro growth
on H11 expression, keratinocytes obtained from a 51-y-old subject
were cultured at a concentration of 105 cells per culture, stained
with H11 antibody, and examined by confocal microscopy at
various times throughout their in vitro lifespan. Staining with
preimmune serum was excluded by gating, as described in Materials
and Methods. NIH3T3 cells (used as feeder layer for keratinocyte
culture) served as control. Consistent with previous reports for
keratinocytes from adult donors (Rheinwald and Green, 1975),
con¯uence was reached at 14±15 d in culture. There was a total of
three consecutive in vitro passages and the cultures had a lifespan of
28 d before growth potential was exhausted. The proportion of
H11+ cells in these cultures increased with time of in vitro growth,
beginning with 25.5 6 5% on day 7 after culture initiation and
reaching 62.8 6 11% and 87.3 6 5% on days 15 and 21,
respectively. At 28 d, when growth potential was exhausted, the
proportion of H11+ cells was reduced to 24.5 6 4%. NIH3T3 did
not stain with the H11 antibody (data not shown).
Expression of the adhesion molecules b1 integrin and b-catenin
and of the differentiation associated keratin K10 (Paramio et al,
1999) was examined in the same cultures studied in parallel. The
proportion of cells with high intensity staining for b-catenin
(bcatbri) increased from 37.6 6 9% on day 11 to 73 6 3% on day 21
and was reduced to 23.2 6 4% on day 28, when growth potential
was exhausted. The proportion of cells with high intensity staining
for b1 integrin (b1bri) remained at 45.3 6 5% to 51 6 10% on days
7±21 in culture, but it also decreased (19.6 6 4%) on day 28. By
contrast, the proportion of K10+ cells was maximal at 7 d (60.3 6
8%) and decreased thereafter (17.2 6 6% and 7.1 6 2% on days 11
and 15, respectively). On day 21, when the proportion of H11+
cells was maximal, only 0.5 6 0.3% of the cells stained with K10
antibody (Fig 4). The data indicate that the proportion of H11+
cells increases with time of in vitro culture, and there is a good
correlation between its expression and that of high levels of
adhesion molecules involved in signal transduction, at least b-
catenin.
H11 protein is associated with the plasma membrane and is
coexpressed with b1 integrin To further examine H11
expression in cultured keratinocytes, we used ¯ow cytometry.
Independently established keratinocyte cultures were studied at
14 d after culture initiation by double staining with FITC-labeled
H11 and phycoerythrin-labeled b1 integrin antibodies. Two cell
populations that do not overlap with the isotype-matched negative
control were resolved based on the intensity of staining with b1
integrin antibody. One of these (b1bri) stained with high intensity
(8 3 102±2 3 103 units) and contained 58% of the cells. The second
population (b1dim) had an approximately 2±20-fold lower staining
intensity (Fig 5A). These results are similar to those previously
reported for b1 integrin (Jones and Watt, 1993). Only one
population that did not overlap with preimmune serum stained
with H11 antibody, but it evidenced a broad spectrum of staining
intensity (102±3 3 103 units) that presumably re¯ects different levels
of H11 expression (Fig 5B). When this population was selected by
gating, it represented 63% of the total cell number (Fig 5C), a
proportion similar to that estimated by confocal microscopy for 14
d cultures (62.8 6 11%; Fig 4). The relationship between H11
levels and cell growth is still unclear. Double staining with H11 and
Figure 2. H11 RNA is expressed in keratinocytes and skin tissues.
(A) Northern blot hybridization with total cellular RNA from the indicated
cell lines with [32P]-labeled H11 and actin cDNA probes. Numbers in the
left margin are molecular size markers. (B) RT-PCR of total RNA from
the indicated human adult tissues, peripheral blood leukocytes (PBL), or
cell lines with H11 or actin primers. The H11 RT-PCR ampli®cation
product is 110 bp.
Figure 3. The H11 protein is expressed in keratinocytes and
phosphorylated. (A) Extracts of 14-d-old keratinocytes (lanes 1, 2),
A431 cells (lanes 3, 4), and 293 cells (lanes 5, 6) were immunoprecipitated
with H11 N-terminal antibody (N; lanes 1, 3, 5) or preimmune serum (P;
lanes 2, 4, 6) and immunoblotted with H11 C-terminal antibody (C; lanes
1, 3, 5) or preimmune serum (P; lanes 2, 4, 6). (B) Extracts of A431 cells
labeled with [32P]-orthophosphate were immunoprecipitated with H11
antibodies N-terminal (N; lane 1) or C-terminal (C; lane 2) or with
preimmune serum (P; lane 3). Numbers in the right margin are molecular
size markers.
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b1 integrin antibodies, however, indicated that H11 is expressed in
virtually all (83%) of the b1bri cells. Only a small proportion
(12.3%) of the b1dim cells were H11+ (Fig 5D).
We considered the possibility that cultures established from
various subjects may differ in the proportion of H11+ cells, and
repeated the experiment with two independently established
keratinocyte cultures, one at 14 d and the other at 7 d after
initiation. In the 14 d culture, the proportion of H11+ cells
(estimated as described in Fig 5B, C) was 67%. The proportion
of b1bri/H11+ cells (estimated as described in Fig 5D) was
98%. In the 7 d culture, the proportion of H11+ cells
(estimated as described in Fig 5B, C) was 32%, consistent with
the results obtained by confocal microscopy (Fig 4). The
proportion of b1bri/H11+ cells in this culture (estimated as
described in Fig 5D) was 77%. The data support previous
conclusions about H11 expression in cultured cells and indicate
that it is coexpressed with high levels of b1 integrin. Essentially
similar conclusions were reached for b-catenin (data not
shown).
H11 is expressed in basal keratinocytes in the
epidermis We used immunohistochemistry with H11 (C-
Figure 5. Flow cytometry of FA-stained 14-
d-old keratinocyte cultures. (A) Keratinocytes
stained with antibody to b1 integrin (dark line) or
isotype-matched negative control (light line). (B)
Keratinocytes stained with H11 antibody (black)
or preimmune serum (white). (C) H11+ keratino-
cytes from panel (B) selected by gating represent
63% of the total cells. (D) Keratinocytes double
stained with FITC-labeled H11 and phycoery-
thrin-labeled b1 integrin antibodies (b1bri/H11+
cells = 83%; b1dim/H11+ cells = 12.3%).
Figure 4. Effect of long-term in vitro culture
on H11 expression. Keratinocyte cultures from
one subject were stained with antibodies to H11
(h), b1 integrin (j), b-catenin (o ), or K10 (q )
at various times in culture and examined by con-
focal microscopy. The percentage of H11+ , b1bri,
bcatbri, and K10+ cells was calculated as described
in Materials and Methods. Results are expressed as
percentage of positive cells 6 SEM.
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terminal) antibody and preimmune serum (control) to examine
H11 expression in the skin. In two of three studied subjects,
staining with H11 antibody was seen in approximately 10%±20% of
the basal keratinocytes. In the third subject, it was seen in
approximately 35%±40% of the basal keratinocytes and in rare
adjacent suprabasal cells, suggesting that H11 may also be expressed
in keratinocytes committed to differentiate that left the basal layer
(Jensen et al, 1999). One area of positive staining is shown in
Fig 6(A), and it consists of cells that stain with apparently different
levels of intensity. Preimmune serum was negative (Fig 6B). The
data indicate that H11 is expressed in the epidermis. The
proportion of staining cells was lower, however, than that seen in
the 21 d cultures (87.3 6 5%), suggesting that H11 expression may
be upregulated during long-term growth in culture.
Antisense H11 ODN inhibits DNA synthesis Having shown
that H11 is expressed in keratinocytes with long-term proliferative
potential, we wanted to know whether it is involved in cell
proliferation. To test this possibility, we took advantage of previous
®ndings from our laboratory (Smith et al, 1986; Kulka et al, 1989,
1993; Feng et al, 1996) and many other laboratories (Ensoli et al,
1994; Nesterova and Cho-Chung, 1995; Care et al, 1996; Vaughn
et al, 1996; Skorski et al, 1997a, b; Agrawal and Zhao, 1998; Alahari
et al, 1998; Citro et al, 1998; Cho-Chung et al, 1999; Robinson-
Benion et al, 2000; Smith and Wickstrom, 2000) that aODNs
speci®cally inhibit the translation, and thereby function, of targeted
genes. A431 cells were exposed (24 h) to different doses of aODN
complementary to the H11 translation initiation site and examined
for DNA synthesis based upon [3H]-TdR incorporation. sODN
and scODN served as controls. Dose-dependent inhibition of [3H]-
TdR incorporation was seen for aODN with maximal inhibition
(89%) at 30 mM. Incorporation was only minimally (10%±15%)
reduced by 30 mM of scODN and there was no inhibition with the
sODN (p < 0.001 by Student's t test for aODN relative to
untreated cells and cells treated with sODN or scODN).
Inhibition was not due to nonspeci®c irreversible toxicity as
[3H]-TdR incorporation levels were restored to those in untreated
cells when aODN was removed and the cells were examined 24 h
later (Fig 7A).
We conclude that inhibition of DNA synthesis is related to
decreased H11 expression, because protein pro®les of [35S]-
methionine-labeled cells indicate that the levels of H11 were also
signi®cantly reduced in cells treated (24 h) with aODN (Fig 8A,
lane 1) compared with untreated cells (Fig 8A, lane 4), or cells
treated with scODN (Fig 8A, lane 2), or sODN-treated cells (data
not shown). Densitometric integration units for H11 in these
Figure 7. aODN complementary to the H11
translation initiation site inhibits DNA synth-
esis. (A) A431 cells were untreated, treated for
24 h with the respective concentrations of
scODN, sODN, or aODN, or aODN for 24 h
followed by 24 h of aODN-free medium
(aODN/±; ), and assayed for [3H]-TdR incorpora-
tion. (B) HeLa (o ) or 293 (h) cells were
untreated or treated with 30 mM of aODN or
scODN and assayed for [3H]-TdR incorporation
(cpm 3 1000) 6 SEM.
Figure 6. H11 is expressed in the epidermis.
(A) Immunohistochemistry of skin tissue with
H11 antibody reveals the presence of an area con-
sisting of H11+ cells that stain with apparently dif-
ferent levels of intensity. Staining is located in
basal cells and appears to be cytoplasmic. A mag-
ni®cation of the cells staining with high intensity
is shown in the box located in the upper right
corner. (B) Skin tissue from the same subject did
not stain with preimmune serum.
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cultures were 3, 72, and 73 for aODN, scODN, and untreated,
respectively. Immunoprecipitation with H11 antibody (N-term-
inal) indicated that H11 is virtually undetectable in cells treated
with aODN (Fig 8B, lane 1), whereas its levels in scODN-treated
cells (Fig 8B, lane 2) are similar to those in untreated cells (Fig 8B,
lane 4). Additional evidence that the inhibition of DNA synthesis
by the aODN is H11 speci®c includes: (i) aODN did not inhibit
DNA synthesis in 293 cells that do not express H11, but DNA
synthesis was inhibited in HeLa cells that express H11 (Fig 7B); (ii)
the protein pro®les other than H11 were virtually identical in
aODN (Fig 8A, lane 1), scODN (Fig 8A, lane 2), and untreated
(Fig 8A, lane 4) cells; and (iii) H11 levels were restored to those in
the untreated cultures upon aODN removal (Fig 8A, lane 3). We
interpret the data to suggest that H11 expression is required for
A431 cell proliferation.
Antisense H11 ODN inhibits keratinocyte proliferation
Because primary keratinocytes may differ from A431 cells, which
are an established cell line, we wanted to examine whether aODN
has a similar effect on keratinocyte proliferation. To begin to
address this question, keratinocytes were cultured in medium with
or without aODN (30 mM) and con¯uence was estimated by
Rhodamine staining 12 d later. As shown in Fig 9 for one such
experiment, proliferation was signi®cantly decreased in the
presence of aODN, with a con¯uence index of 0.20±0.24
compared with 0.74±0.76 in the untreated cultures. Inhibition
was reversible. Thus, cultures treated with aODN for 24 h at any
time during the ®rst 14 d after initiation had a 25%±35% lower
number of colonies than the untreated cultures, but the number
was restored to that of the untreated cultures 24 h after aODN
removal. We interpret the data to suggest that H11 expression is
required for keratinocyte proliferation in vitro.
DISCUSSION
The salient feature of the data presented in this report is the
isolation of a novel gene (H11) that codes for a protein that is
similar to the HSV-2 protein RR1 PK and appears to be required
for keratinocyte growth. The following comments seem pertinent
with respect to these ®ndings.
The HSV-1 and HSV-2 RR1 genes differ from their counter-
parts in eukaryotic and prokaryotic cells and in other viruses in that
they possess unique 5¢-terminal domains that code for serine-
threonine PKs (Chung et al, 1989, 1990; Luo et al, 1991; Luo and
Aurelian, 1992; Cooper et al, 1995; Nelson et al, 1996; Peng et al,
1996; Aurelian, 1998; Smith et al, 1998). These PKs function with
only eight catalytic motifs compared with the 12 motifs conserved
in most other PKs (Taylor et al, 1992; Hanks and Hunter, 1995)
and are members of a distinct phylogenetic subfamily (Hunter et al,
1995a). Another cellular PK that functions with a small number of
conserved catalytic motifs is FAST, which is only 12% identical to
RR1 PK when the PK motifs are anchored (Tian et al, 1995). The
HSV-2 RR1 PK protein has a functional transmembrane domain,
it is myristylated, and it is associated with the plasma membrane
(Chung et al, 1990; Luo and Aurelian, 1992; Smith et al, 1994). It
interacts with signaling proteins to activate the Ras/MEK/MAPK
mitogenic pathway (Smith et al, 1994; Hunter et al, 1995b) and it is
required for HSV-2 growth (Smith et al, 1992; 1998). Previous
studies suggested that RR1 PK may have originated from a co-
opted cellular gene (Smith et al, 1991). Homologous genes were
not cloned, however, and their function is unknown.
The studies described in this report were designed to address
these questions. They are based on previous, unpublished ®ndings
that a 25 kDa protein in HeLa and A431 cells is recognized by
antibodies to RR1 PK, thereby predicating our choice to screen
the commercially available HeLa cDNA library with the RR1 PK
antibodies. We focused on H11 because: (i) the gene was
independently cloned from cultured cells in the outer root sheath
of the hair follicle by differential display assays (unpublished) and (ii)
the size of H11 cDNA is similar to that of RR1 PK. Computer-
assisted analysis indicated the presence in the H11 ORF of seven
potential conserved PK catalytic motifs, myristylation sites, and an
SH3-binding module located between the PK catalytic motifs, as
previously shown for RR1 PK (Nelson et al, 1996). Upon direct
alignment with anchored PK motifs, H11 was 30% identical to
HSV-2 RR1 PK over its PK catalytic domain (115 amino acids).
The biologic and evolutionary signi®cance of this level of identity is
unclear, particularly in relation to the possibility that RR1 PK may
have originated from a co-opted cellular gene. In this context, it
may be signi®cant that H11 was found to differ from all other
known proteins when using one computer program whereas in
another program it was 40% identical to hsp27. H11 was not
recognized by polyclonal antibody to hsp27 in immunoprecipita-
tion studies, however (Smith et al, 2000b), suggesting that it is
Figure 8. aODN inhibits H11 expression. (A) A431 cells treated for
24 h with 30 mM of aODN (lane 1), scODN (lane 2), aODN followed
(24 h) by aODN-free medium (lane 3), or untreated (lane 4) were labeled
with [35S]-methionine during the last 4 h and the proteins were resolved by
electrophoresis on 8.5% SDS-acrylamide gels. Numbers in the left margin
represent molecular size markers. H11 and actin are identi®ed. (B)
Immunoprecipitation of extracts in (A) with H11 N-terminal antibody.
Figure 9. H11 aODN inhibits keratinocyte proliferation. Keratino-
cytes were cultured in medium containing 30 mM of aODN (A) or ODN-
free medium (B, C) and stained with Rhodamine B at 12 d in culture.
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antigenically and biologically distinct. Nonetheless, members of the
small hsp family have a wide spectrum of biologic activities, as also
evidenced by the ®nding that a-crystallin has PK activity
(Kantarow and Piatigorsky, 1994).
Using northern blot hybridization and RT-PCR assays, H11
RNA was seen in HeLa and A431 cells as well as in skin tissues. It
was not seen in 293 cells and in the other studied tissues, but
additional adult and fetal tissues must be studied in order to
determine the spectrum of H11 expression. Immunoprecipitation/
immunoblotting assays indicated that H11 protein is expressed in
A431 cells and in cultured keratinocytes, and it is phosphorylated,
like RR1 PK. The immunoprecipitation/immunoblotting assays
were speci®c, as evidenced by the failure to detect the H11 protein
in 293 cells that are negative for H11 RNA and the ®nding that the
protein was recognized by the H11 antibodies, that, respectively,
recognize amino acids located at the N-terminus and C-terminus of
the H11 protein, whereas preimmune serum was negative.
Consistent with its similarity to RR1 PK, the H11 protein was
also recognized by the RR1 PK antibodies (data not shown). FA
staining of un®xed cells and confocal microscopy of thin optical
sections throughout the entire thickness of FA stained keratinocytes
(data not shown) indicated that H11 is associated with the plasma
membrane. This association may be facilitated by myristylation
(Schultz et al, 1985) or due to protein±protein interaction involving
SH3 modules (Pawson, 1995), as is the case for RR1 PK (Chung
et al, 1989; Luo and Aurelian, 1992; Nelson et al, 1996).
Longitudinal studies of keratinocytes from adult subjects
indicated that the proportion of H11+ cells increased with time
in culture. Highest levels (87.3 6 5%) were seen on day 21, shortly
before all growth potential was exhausted (on days 23±28). H11
was also expressed in skin tissues as evidenced by immunohisto-
chemistry. Staining was restricted to the epidermis and seemed to
localize almost exclusively to the basal layer. The proportion of
H11+ positive cells in the epidermis ranged between 10% and 40%
in the three studied subjects, a proportion lower than that seen at
14±21 d in culture. This may indicate that H11 expression is
upregulated in vitro, or alternatively that H11+ expression imparts
in vitro growth potential. Present data do not differentiate between
these two interpretations. They also do not address the relationship
between the different levels of H11 expressed by cells in the
epidermis and in vitro and their ability to grow in culture. Final
conclusions must await the results of studies that examine the in
vitro growth of freshly disaggregated keratinocytes that express
different levels of H11 or are H11 negative.
Double staining experiments indicated that H11 is coexpressed
with high levels of adhesion molecules involved in signal
transduction such as b1 integrin and b-catenin. Examination of
14 d and 7 d keratinocyte cultures indicated that virtually all (78%±
98%) of the b1bri cells were also H11+. Unlike H11+ cells,
however, the proportion of b1bri cells did not increase with time
and remained approximately 40%±50% throughout the culture
lifespan. The proportion of bcatbri keratinocytes also increased with
time in culture and virtually all bcatbri cells (85%±95%) were also
H11+ (data not shown). We believe that the estimated proportions
of cells expressing these markers are accurate, because similar results
were obtained in confocal microscopy studies in which 1000 cells
were counted in each group, and by ¯ow cytometry, which is an
established quantitative procedure. In all assays, nonspeci®c
reactivity was excluded by staining with preimmune serum or
isotype-matched negative control reagent, and similar results were
obtained with both H11 antibodies. Speci®city is also supported by
the ®nding that the proportions of cells staining with the three
antibodies (H11, b1 integrin, and b-catenin) were similarly
decreased when in vitro growth potential was exhausted (day 28
in culture).
Because b-catenin and b1 integrin are involved in cell
proliferation pathways (Aplin and Juliano, 1999; Morin, 1999)
and H11 was coexpressed with these proteins, we wanted to know
whether H11 is involved in cell proliferation. To begin testing this
hypothesis, we used aODNs, which are widely accepted as a
method to modulate gene expression in cell culture (Smith et al,
1986; Kulka et al, 1989; Vaughn et al, 1995; Care et al, 1996; Feng
et al, 1996; Alahari et al, 1998; Citro et al, 1998) and in animals
(Kulka et al, 1993; Ensoli et al, 1994; Nesterova and Cho-Chung,
1995, 1997b; Skorski et al, 1997a; Cho-Chung et al, 1999;
Robinson-Benion et al, 2000) and have recently moved into the
clinical setting (Agrawal, 1998; Smith and Wickstrom, 2000). We
found that an aODN that inhibits H11 expression causes a
signi®cant decrease (74%±81%) in cell growth, as determined by
DNA synthesis and con¯uence growth assays, as well as colony
counts (data not shown). Inhibition was speci®c, as evidenced by
the ®ndings that: (i) it was dose dependent and reversible; (ii) H11
expression and cell growth were not inhibited by sODN or
scODN; (iii) aODN did not inhibit the expression of proteins other
than H11; and (iv) aODN did not inhibit the growth of 293 cells
that do not express H11. The role played by H11 in keratinocyte
proliferation including its potential interaction with adhesion and/
or other molecules involved in mitogenic signaling is at present
unknown. Integrins are involved in signal transduction, either by
directly generating signals or by modulating signals generated by
other receptors (Humphries, 1996; Kolanus and Seed, 1997; Aplin
and Juliano, 1999; Giancotti and Ruoslahti, 1999). Integrin-
mediated modulation of signaling impacts upon the control of the
cell cycle (Assoian and Zhu, 1997; Pozzi et al, 1998; Giancotti and
Ruoslahti, 1999) and upon the regulation of apoptosis (Watt et al,
1993; Rich et al, 1996; Giancotti and Ruoslahti, 1999). The ®nding
that H11 is required for cell proliferation is particularly signi®cant
from the standpoint of its similarity to RR1 PK, which activates the
Ras/MEK/MAPK mitogenic pathway, thereby causing cell
proliferation (Smith et al, 1994; Hunter et al, 1995b; Aurelian,
1998). It is also signi®cant that H11 is coexpressed with b1 integrin,
which cooperates with MAPK to maintain proliferative potential
(Zhu et al, 1999), and b-catenin, which contributes to this potential
in keratinocytes (Zhu and Watt, 1999) and is involved in
proliferative signaling pathways (Morin, 1999). Indeed, H11 might
be a partner protein that functions in signaling transduction from
the integrin receptor (Hemler, 1998; Porter and Hogg, 1998;
Zhang and Hemler, 1999). H11 could also cooperate with b-
catenin, which is also involved in signaling (Morin, 1999), or with
other proteins that interact with transmembrane receptors at the
intracellular or transmembrane domains (Munger et al, 1998).
Ongoing studies are designed to test the hypothesis that H11
functions in signaling pathways involved in the regulation of the
cell cycle and to examine its relationship to differentiation.
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